MX2011008876A - Metabolitos analogos de ceramida. - Google Patents
Metabolitos analogos de ceramida.Info
- Publication number
- MX2011008876A MX2011008876A MX2011008876A MX2011008876A MX2011008876A MX 2011008876 A MX2011008876 A MX 2011008876A MX 2011008876 A MX2011008876 A MX 2011008876A MX 2011008876 A MX2011008876 A MX 2011008876A MX 2011008876 A MX2011008876 A MX 2011008876A
- Authority
- MX
- Mexico
- Prior art keywords
- ceramide
- relates
- metabolites
- analogous
- analogous metabolites
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Esta invención se refiere a ciertos análogos de ceramida del FTY720 (2-amino-2-[2-(4-octilfenil)-etil]-propano-1,3-diol;fingoli mod). En particular, la presente invención se refiere a composiciones farmacéuticas que comprenden estos compuestos, así como a procesos para su preparación, y a su uso en el tratamiento de condiciones autoinmunes, tales como esclerosis múltiple.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09153550 | 2009-02-24 | ||
PCT/EP2010/052231 WO2010097371A1 (en) | 2009-02-24 | 2010-02-23 | Ceramide-analogous metabolites |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011008876A true MX2011008876A (es) | 2011-09-21 |
Family
ID=40447014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011008876A MX2011008876A (es) | 2009-02-24 | 2010-02-23 | Metabolitos analogos de ceramida. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8673982B2 (es) |
EP (1) | EP2400960B1 (es) |
JP (1) | JP2012518671A (es) |
KR (1) | KR20110126631A (es) |
CN (1) | CN102333530A (es) |
AU (1) | AU2010217605B2 (es) |
BR (1) | BRPI1007994A2 (es) |
CA (1) | CA2752003A1 (es) |
ES (1) | ES2411138T3 (es) |
MX (1) | MX2011008876A (es) |
PL (1) | PL2400960T3 (es) |
PT (1) | PT2400960E (es) |
RU (1) | RU2011138963A (es) |
WO (1) | WO2010097371A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014063057A1 (en) * | 2012-10-19 | 2014-04-24 | Texas Tech University System | Compositions and methods for the treatment of parkinson's disease |
EP2927211A4 (en) * | 2012-11-30 | 2016-07-20 | Amorepacific Corp | PESUDOCERAMIDE TYPE UNDEED COMPOUND AND PROCESS FOR PRODUCING THE SAME |
AU2014224237B2 (en) * | 2013-03-05 | 2017-07-20 | Biocon Limited | A process for the preparation of 2-amino-1,3-propane diol compounds and salts thereof |
KR101510683B1 (ko) * | 2013-09-03 | 2015-04-10 | (주)네오팜 | 카나비노이드 수용체에 길항작용을 가지는 신규한 유사 세라마이드 유도체 및 이를 포함하는 약학 또는 화장품 조성물 |
EP3118621A1 (en) | 2015-07-14 | 2017-01-18 | Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2126658T3 (es) | 1992-10-21 | 1999-04-01 | Yoshitomi Pharmaceutical | Compuesto de 2-amino-1,3-propanodiol e inmunosupresor. |
US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
PT778263E (pt) * | 1994-08-22 | 2002-06-28 | Mitsubishi Pharma Corp | Composto de benzeno e sua utilizacao farmaceutica |
MX2007001236A (es) * | 2004-07-30 | 2007-03-23 | Novartis Ag | Formulaciones de compuestos de 2-amino-1, 3-propanodiol. |
GT200600350A (es) * | 2005-08-09 | 2007-03-28 | Formulaciones líquidas | |
CN101346346B (zh) * | 2005-12-15 | 2012-08-22 | 田边三菱制药株式会社 | 胺化合物及其医药用途 |
CN101240002B (zh) * | 2007-02-07 | 2011-01-26 | 首都医科大学 | 脂肪酰氨基酰阿糖胞苷缀合物、其制备方法和应用 |
-
2010
- 2010-02-23 CA CA2752003A patent/CA2752003A1/en not_active Abandoned
- 2010-02-23 BR BRPI1007994A patent/BRPI1007994A2/pt not_active IP Right Cessation
- 2010-02-23 WO PCT/EP2010/052231 patent/WO2010097371A1/en active Application Filing
- 2010-02-23 RU RU2011138963/15A patent/RU2011138963A/ru not_active Application Discontinuation
- 2010-02-23 MX MX2011008876A patent/MX2011008876A/es not_active Application Discontinuation
- 2010-02-23 AU AU2010217605A patent/AU2010217605B2/en not_active Ceased
- 2010-02-23 JP JP2011551479A patent/JP2012518671A/ja active Pending
- 2010-02-23 ES ES10705160T patent/ES2411138T3/es active Active
- 2010-02-23 KR KR1020117019540A patent/KR20110126631A/ko not_active Application Discontinuation
- 2010-02-23 CN CN2010800089918A patent/CN102333530A/zh active Pending
- 2010-02-23 US US13/202,939 patent/US8673982B2/en not_active Expired - Fee Related
- 2010-02-23 PL PL10705160T patent/PL2400960T3/pl unknown
- 2010-02-23 EP EP10705160.9A patent/EP2400960B1/en not_active Not-in-force
- 2010-02-23 PT PT107051609T patent/PT2400960E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EP2400960B1 (en) | 2013-04-17 |
BRPI1007994A2 (pt) | 2018-03-13 |
US20110306672A1 (en) | 2011-12-15 |
PL2400960T3 (pl) | 2013-08-30 |
WO2010097371A1 (en) | 2010-09-02 |
US8673982B2 (en) | 2014-03-18 |
ES2411138T3 (es) | 2013-07-04 |
PT2400960E (pt) | 2013-06-28 |
KR20110126631A (ko) | 2011-11-23 |
CA2752003A1 (en) | 2010-09-02 |
JP2012518671A (ja) | 2012-08-16 |
RU2011138963A (ru) | 2013-04-10 |
CN102333530A (zh) | 2012-01-25 |
EP2400960A1 (en) | 2012-01-04 |
AU2010217605B2 (en) | 2012-07-26 |
AU2010217605A1 (en) | 2011-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA109661C2 (uk) | Фармацевтична композиція співкристалів трамадолу і коксибів | |
WO2012056458A3 (en) | Intermediate compounds and process for the preparation of fingolimod | |
ECSP12012318A (es) | Inhibidores de pirazolil quinazolina cinasa | |
IN2012DN01435A (es) | ||
HRP20200249T1 (hr) | Formulacije koje sadrže 2-amino-2-[2-(4-oktilfenil)etil]propan-1,3-diol | |
IN2012DN01434A (es) | ||
EA017091B9 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
IN2012DN02139A (es) | ||
MX2011008876A (es) | Metabolitos analogos de ceramida. | |
CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
GEP20156231B (en) | Agomelatine hydrochloride hydrate and preparation there of | |
IL206197A (en) | Crystalline forms of the compound (r1, r2) –3– (3– dimethylamino – 1 – ethyl – 2 – methyl-profile) –phenol processes for their preparation, pharmaceutical compositions containing them, and their use in the preparation of pain treatment compositions | |
MX2010009931A (es) | Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles. | |
BR112013028607A2 (pt) | composições sólidas contendo éter glicólico e água | |
CO6680629A2 (es) | Compuestos con actividad antibacteriana contra clsotridium | |
ECSP13013043A (es) | Composición oral líquida que comprende sodio divalproex y proceso para preparar la misma | |
SG143203A1 (en) | Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome | |
MX361369B (es) | Modificaciones cristalinas estables de cloruro de dotap. | |
WO2013033602A3 (en) | Fatty acid amides, compositions and methods of use | |
IN2012DN06600A (es) | ||
CO6361860A2 (es) | (beta)-hidroxi-y-aminofosfonatos y metodos para la preparacion y uso de los mismos | |
TN2010000584A1 (en) | Paediatric compositions for treating multiple scleoris | |
IN2013MU01225A (es) | ||
TN2011000049A1 (en) | 5-alkynyl-pyrimidines | |
UA42862U (uk) | ЗАСТОСУВАННЯ М'ЯКОЇ ЛІКАРСЬКОЇ ФОРМИ, ЯКА МІСТИТЬ АКТИВНУ РЕЧОВИНУ β-ФЕНІЛЕТИЛАМІД 2-ОКСИСУКЦИНАНІЛОВОЇ КИСЛОТИ, ДЛЯ ЛІКУВАННЯ ОПІКОВИХ УРАЖЕНЬ ШКІРИ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |